Atsushi Shiozaki

Dr. Atsushi Shiozaki


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2013
Verified
Journal Article
Closed access
TATomohiro Arita
Tomohiro Arita
DIDaisuke Ichikawa
Daisuke Ichikawa
HKhirotaka konishi
hirotaka konishi
SKShuhei Komatsu
Shuhei Komatsu
ASAtsushi Shiozaki
Atsushi Shiozaki
EOEigo Otsuji
Eigo Otsuji

14 December 2018 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
GSGen Suzuki
Gen Suzuki
Hideya YamazakiHideya Yamazaki
Hideya Yamazaki
NANorihiro Aibe
Norihiro Aibe
KMKoji Masui
Koji Masui
NSNaomi Sasaki
Naomi Sasaki
KYKei Yamada
Kei Yamada
The standard treatment for superficial esophageal cancer (SEC) involving muscularis mucosal (T1a-MM) or submucosal (T1b) invasion has been the surgical resection of the esophagus. However, esophagectomy with extended lymph node dissection is highly invasive. Recent reports have shown that endoscopic submucosal dissection (ESD) followed by chemoradiotherapy (CRT) has promising results and might become a new therapeutic approach. This retrospective study aimed to elucidate the efficacy and safety of this new treatment. Patients with clinical stage T1b tumor without apparent metastasis treated with ESD followed by CRT from 2014 to 2017 (the CRT group) were included. The outcomes on disease-free survival (DFS) of this group were compared with those of consecutive patients in a historical control group who underwent ESD followed by esophagectomy (the esophagectomy group) between 2008 and 2015. Of 32 patients analyzed, 16 were in the CRT group and 16 with similar stage cancer were in the esophagectomy group. Radiotherapy was completed in all patients, and the incidence of grade ≥ 3 nonhematologic adverse events was 6%. The 2-year overall survival rates were 100%, and locoregional control was achieved in all patients in the CRT group, and the 2-year DFS rates were 88 and 100% for the CRT and esophagectomy groups, respectively, without significant differences. Our data confirmed our new approach as being safe and effective for locoregional control and may provide a nonsurgical treatment option for patients with clinical stage T1b tumors.

Verified
Journal Article
Open access
PDF file
TKTstutomu Kawaguchi
Tstutomu Kawaguchi
SKShuhei Komatsu
Shuhei Komatsu
DIDaisuke Ichikawa
Daisuke Ichikawa
MTMasahiro Tsujiura
Masahiro Tsujiura
HTHiroki Takeshita
Hiroki Takeshita
EOEigo Otsuji
Eigo Otsuji
MicroRNAs (miRNAs) are short noncoding RNAs that post-transcriptionally regulate gene expression and play important roles in various physiological and developmental processes such as oncogenic or tumor suppressive regulators. Specific miRNA expression signatures have been identified in a number of human cancers. Cell-free miRNAs have recently been stably detected in plasma and serum (circulating miRNAs), and their presence in blood has attracted the attention of researchers due to their potential as non-invasive biomarkers. Circulating miRNAs have emerged as tumor-associated biomarkers that reflect not only the existence of early-stage tumors, but also the dynamics and status of advanced stage tumors, tumor recurrence, and drug sensitivities. This methodology for liquid biopsy may provide non-invasive and reproductive biomarkers and individualized therapeutic strategies for cancer patients. We herein review the current phase of biological and clinical research on the circulating miRNAs of solid cancers, particularly digestive tract cancers, and discuss future perspectives. The present review may be beneficial for future research on miRNAs used to detect various cancers.

1 January 2014 in World Journal of Gastroenterology
Verified
Journal Article
Open access
ASAtsushi Shiozaki
Atsushi Shiozaki
YNYoshito Nako
Yoshito Nako
DIDaisuke Ichikawa
Daisuke Ichikawa
HKHirotaka Konishi
Hirotaka Konishi
SKShuhei Komatsu
Shuhei Komatsu
EOEigo Otsuji
Eigo Otsuji
Role of the Na+/K+/2Cl- cotransporter NKCC1 in cell cycle progression in human esophageal squamous cell carcinoma

7 April 2017 in Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
ASAtsushi Shiozaki
Atsushi Shiozaki
MKMichihiro Kudou
Michihiro Kudou
DIDaisuke Ichikawa
Daisuke Ichikawa
HFHitoshi Fujiwara
Hitoshi Fujiwara
HSHiroki Shimizu
Hiroki Shimizu
EOEigo Otsuji
Eigo Otsuji

9 May 2013 in Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
HSHiroki Shimizu
Hiroki Shimizu
ASAtsushi Shiozaki
Atsushi Shiozaki
DIDaisuke Ichikawa
Daisuke Ichikawa
HFHitoshi Fujiwara
Hitoshi Fujiwara
HKHirotaka Konishi
Hirotaka Konishi
EOEigo Otsuji
Eigo Otsuji